Krystal Biotech Inc (KRYS)
Days of inventory on hand (DOH)
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inventory turnover | 8.87 | 13.82 | 18.08 | 83.31 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
DOH | days | 41.17 | 26.41 | 20.19 | 4.38 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
March 31, 2024 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 8.87
= 41.17
The Days of Inventory on Hand (DOH) for Krystal Biotech Inc has shown fluctuations over the reported periods. The trend indicates a significant increase in DOH from 4.38 days on June 30, 2023, to 41.17 days on March 31, 2024. This suggests a potential build-up of inventory levels relative to sales, which may impact working capital efficiency and carrying costs. Further analysis is recommended to understand the reasons behind this increase and to assess its impact on the company's operational performance and financial health.
Peer comparison
Mar 31, 2024
Company name
Symbol
DOH
Krystal Biotech Inc
KRYS
41.17
Amgen Inc
AMGN
194.11
Bio-Techne Corp
TECH
97.42
Biogen Inc
BIIB
166.44
Gilead Sciences Inc
GILD
41.50
Halozyme Therapeutics Inc
HALO
110.31
Moderna Inc
MRNA
10.31
Neurocrine Biosciences Inc
NBIX
15.05
Regenxbio Inc
RGNX
—
Repligen Corporation
RGEN
124.44
Vericel Corp Ord
VCEL
77.12